|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 259.70 CHF | +1.05% |
|
-0.08% | +1.64% |
| May. 15 | Foreign companies eye US expansion to lessen fallout from tariffs | RE |
| May. 15 | Roche: receives FDA approval for cancer drug | CF |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions on site
| Capitalization | 208B 248B 222B 187B 347B 21,261B 388B 2,430B 949B 9,652B 932B 913B 36,183B | P/E ratio 2025 * |
14.1x | P/E ratio 2026 * | 13x |
|---|---|---|---|---|---|
| Enterprise value | 219B 262B 234B 197B 366B 22,415B 409B 2,562B 1,001B 10,176B 983B 962B 38,146B | EV / Sales 2025 * |
3.47x | EV / Sales 2026 * | 3.25x |
| Free-Float |
87.84% | Yield 2025 * |
3.84% | Yield 2026 * | 3.94% |
More valuation ratios
* Estimated data
More news
Last Transcript: Roche Holding AG
| ROCHE HOLDINGS AG : Berenberg remains Neutral | May. 16 | ZD |
| ROCHE HOLDINGS AG : UBS gives a Buy rating | May. 09 | ZD |
| ROCHE HOLDINGS AG : JP Morgan reiterates its Sell rating | May. 07 | ZD |
| ROCHE HOLDINGS AG : Sell rating from JP Morgan | Apr. 30 | ZD |
| HSBC Downgrades Roche to Hold, Cuts PT | Apr. 28 | MT |
More press releases
More news
| 1 day | +1.05% | ||
| 1 week | -0.08% | ||
| Current month | -3.56% | ||
| 1 month | +1.68% | ||
| 3 months | -11.82% | ||
| 6 months | +1.52% | ||
| Current year | +1.64% |
| 1 week | 246 |  | 265.1 |
| 1 month | 246 | | 274.6 |
| Current year | 231.9 | | 313.8 |
| 1 year | 226.5 | | 313.8 |
| 3 years | 212.9 | | 335.85 |
| 5 years | 212.9 | | 404.2 |
| 10 years | 206.35 | | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 58 | 2011-06-05 |
Wafaa Mamilli
CTO | Chief Tech/Sci/R&D Officer | 58 | 2025-02-09 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 67 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 58 | 2023-03-14 |
| Director/Board Member | 72 | 2015-03-02 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 9.03% | 121 M€ | -.--% | - | |
| 8.46% | 21 M€ | -0.27% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.05% | -0.08% | +14.15% | -18.59% | 246B | ||
| +3.50% | +0.79% | -3.76% | +159.71% | 658B | ||
| +1.15% | -2.78% | -0.88% | -14.43% | 360B | ||
| +1.29% | -0.84% | +12.35% | +19.88% | 321B | ||
| -1.81% | -0.55% | -53.49% | +13.88% | 289B | ||
| +1.25% | +0.40% | -1.96% | +5.92% | 211B | ||
| +1.85% | +1.93% | -15.13% | +0.43% | 209B | ||
| +1.68% | -2.05% | -42.26% | -15.87% | 188B | ||
| +1.15% | +0.13% | -14.62% | +11.92% | 146B | ||
| +1.02% | -0.61% | -20.78% | -54.27% | 128B | ||
| Average | +0.49% | -1.44% | -12.64% | +10.86% | 275.73B | |
| Weighted average by Cap. | +0.42% | -1.69% | -9.84% | +35.86% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 63.17B 75.4B 67.5B 56.75B 105B 6,453B 118B 738B 288B 2,929B 283B 277B 10,982B | 65.9B 78.66B 70.42B 59.2B 110B 6,732B 123B 769B 301B 3,056B 295B 289B 11,456B |
| Net income | 14.07B 16.79B 15.03B 12.64B 23.44B 1,437B 26.22B 164B 64.17B 652B 62.99B 61.69B 2,446B | 15.21B 18.16B 16.26B 13.67B 25.35B 1,554B 28.36B 178B 69.4B 706B 68.13B 66.72B 2,645B |
| Net Debt | 11.29B 13.48B 12.07B 10.14B 18.81B 1,153B 21.05B 132B 51.5B 524B 50.56B 49.52B 1,963B | 5.73B 6.84B 6.13B 5.15B 9.55B 586B 10.68B 66.93B 26.15B 266B 25.67B 25.14B 997B |
More financial data
* Estimated data
Employees
103,249
Sector
Pharmaceuticals
Calendar
May. 27
- Investor Day
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-05-16 | 259.70 CHF | +1.05% | 1,706,043 |
| 25-05-15 | 257.00 CHF | +0.98% | 831,299 |
| 25-05-14 | 254.50 CHF | -1.74% | 1,233,370 |
| 25-05-13 | 259.00 CHF | -1.11% | 1,052,072 |
| 25-05-12 | 261.90 CHF | +1.67% | 2,082,326 |
Delayed Quote Swiss Exchange, May 16, 2025 at 11:31 am EDT
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
259.70CHF
Average target price
302.63CHF
Spread / Average Target
+16.53%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROG Stock
Select your edition
All financial news and data tailored to specific country editions
